Feline Endocrine Disorders: Overview and Diagnostic Approach

This article provides a systematic overview of common feline endocrine diseases for veterinary clinicians. The focus is on hyperthyroidism, diabetes mellitus, and acromegaly, with attention to diagnostic differentiation and management principles. The content is based on published guidelines and peer-reviewed literature. It is intended to support clinical decision-making and does not replace individual patient assessment or professional veterinary judgment.

At a Glance

The table below summarizes key features of the three most common feline endocrinopathies. This comparison aids initial differentiation based on signalment, history, and physical examination findings.

Clinical Presentation and Signalment

Hyperthyroidism

Feline hyperthyroidism is a common endocrine disorder in older cats. The median age at diagnosis is approximately 12 to 13 years, with a range of 4 to 20 years. There is no strong breed or sex predilection. The condition results from excessive production of thyroid hormones by a functional thyroid adenoma or adenomatous hyperplasia. Clinical signs reflect a hypermetabolic state. Owners often report weight loss despite a good or increased appetite. Other common signs include hyperactivity, restlessness, vomiting, diarrhea, polyuria, and polydipsia. On physical examination, a palpable thyroid nodule is frequently present. Tachycardia, a heart murmur, and a thin body condition are also common findings. The Merck Veterinary Manual provides a general overview of cat health and common conditions (Merck Veterinary Manual, https://www.merckvetmanual.com/).

Diabetes Mellitus

Feline diabetes mellitus is a disorder of insulin secretion, insulin action, or both. It is most commonly diagnosed in middle-aged to older cats. Overweight and obese cats are at increased risk. Burmese cats may have a higher prevalence. Clinical signs include polyuria, polydipsia, polyphagia, and weight loss. Lethargy and weakness are also common. A plantigrade stance due to diabetic neuropathy may be observed. Physical examination may reveal hepatomegaly, cataracts, and poor hair coat. The 2023 AAHA Selected Endocrinopathies of Dogs and Cats Guidelines provide a framework for diagnosis and management (2023 AAHA Selected Endocrinopathies of Dogs and Cats Guidelines, Journal of the American Animal Hospital Association, 2023, https://pubmed.ncbi.nlm.nih.gov/37167252).

Acromegaly

Feline acromegaly, or hypersomatotropism, is caused by a growth hormone-secreting pituitary adenoma. It is most often diagnosed in middle-aged to older male cats. Affected cats are frequently overweight or obese. Clinical signs are related to the effects of excess growth hormone and insulin-like growth factor-1. Polyuria and polydipsia are common, often due to concurrent diabetes mellitus. Weight gain or obesity, despite insulin therapy, is a hallmark. Physical examination may reveal a large body size, broad head, prognathia inferior (overgrowth of the mandible), and organomegaly (liver, heart, kidneys). Acromegaly should be suspected in any diabetic cat with poor glycemic control despite high insulin doses.

Diagnostic Approach

Initial Assessment

The diagnostic approach to a suspected feline endocrine disorder begins with a thorough history and physical examination. Key historical points include age, breed, body condition, appetite, water intake, urination frequency, and any changes in behavior or activity. Physical examination should include careful palpation of the ventral neck for thyroid nodules, cardiac auscultation, and assessment of body condition and muscle mass. The catvets.com guidelines offer resources for feline health and disease management (catvets.com, https://catvets.com/guidelines).

Laboratory Testing

Initial laboratory testing typically includes a complete blood count, serum biochemistry profile, and urinalysis. These tests help identify common comorbidities and rule out other causes of clinical signs. Specific endocrine tests are then selected based on the suspected disorder.

For hyperthyroidism, the initial test is a serum total T4 concentration. If the total T4 is within the reference range but clinical suspicion remains high, a free T4 by equilibrium dialysis may be measured. The 2016 AAFP Guidelines for the Management of Feline Hyperthyroidism provide detailed recommendations (2016 AAFP Guidelines for the Management of Feline Hyperthyroidism, Journal of Feline Medicine and Surgery, 2016, https://pubmed.ncbi.nlm.nih.gov/27143042).

For diabetes mellitus, a fasting blood glucose concentration is the initial test. A single elevated glucose measurement must be interpreted with caution due to stress hyperglycemia. Fructosamine, a glycated protein, reflects average blood glucose over the preceding 1 to 2 weeks and is useful for confirming persistent hyperglycemia. Urinalysis should include assessment for glucose and ketones.

For acromegaly, the initial screening test is serum insulin-like growth factor-1 (IGF-1). An elevated IGF-1 concentration supports the diagnosis. Confirmation requires demonstration of a pituitary mass on advanced imaging (CT or MRI) and, in some cases, measurement of growth hormone.

Advanced Diagnostic Imaging

Advanced imaging is indicated for suspected acromegaly and for some cases of hyperthyroidism when ectopic thyroid tissue or intrathoracic goiter is suspected. CT and MRI are used to identify pituitary masses in acromegaly. For hyperthyroidism, thyroid scintigraphy can confirm the diagnosis and identify the location of functional thyroid tissue. The ACVIM provides consensus statements and guidelines for various endocrine disorders (ACVIM, https://www.acvim.org/).

Management Principles

Hyperthyroidism

Management options for feline hyperthyroidism include medical therapy, dietary iodine restriction, radioactive iodine therapy, and surgical thyroidectomy. The choice depends on the individual cat, the presence of comorbidities, and owner preferences. Medical therapy with methimazole is effective for long-term control. Dietary iodine restriction using a prescription diet can also be effective. Radioactive iodine therapy is a curative option with a high success rate. Surgical thyroidectomy is another curative option but carries risks, particularly in cats with cardiac disease. The 2016 AAFP Guidelines for the Management of Feline Hyperthyroidism provide a comprehensive review of treatment options (2016 AAFP Guidelines for the Management of Feline Hyperthyroidism, Journal of Feline Medicine and Surgery, 2016, https://pubmed.ncbi.nlm.nih.gov/27143042).

Diabetes Mellitus

The cornerstone of diabetes management is insulin therapy. Long-acting insulin analogs, such as glargine and detemir, are commonly used. Porcine lente insulin is also an option. Dietary management is important, with a high-protein, low-carbohydrate diet recommended. Weight management is crucial for overweight cats. Monitoring includes serial blood glucose curves, fructosamine measurements, and owner observation of clinical signs. The goal is to achieve glycemic control while avoiding hypoglycemia. The 2023 AAHA Selected Endocrinopathies of Dogs and Cats Guidelines provide a framework for insulin therapy and monitoring (2023 AAHA Selected Endocrinopathies of Dogs and Cats Guidelines, Journal of the American Animal Hospital Association, 2023, https://pubmed.ncbi.nlm.nih.gov/37167252).

Acromegaly

Management of acromegaly focuses on controlling the pituitary tumor and managing the associated diabetes mellitus. Radiation therapy is the most common treatment for the pituitary tumor. Medical therapy with pasireotide or cabergoline may be used in some cases. Surgical hypophysectomy is an option but is not widely available. Insulin therapy for the associated diabetes often requires high doses. The goal is to improve glycemic control and reduce the clinical signs of acromegaly. The Peculiarities of feline hyperadrenocorticism: Update on diagnosis and treatment article provides context on pituitary disorders in cats (Peculiarities of feline hyperadrenocorticism: Update on diagnosis and treatment, Journal of Feline Medicine and Surgery, 2017, https://pubmed.ncbi.nlm.nih.gov/28838299).

Less Common Feline Endocrine Disorders

Hyperadrenocorticism (Cushing's Syndrome)

Feline hyperadrenocorticism is rare. It is most often caused by a pituitary adenoma (pituitary-dependent hyperadrenocorticism) or, less commonly, an adrenal tumor. Clinical signs include polyuria, polydipsia, polyphagia, weight loss, muscle wasting, a pot-bellied appearance, and fragile skin. Diagnosis is challenging and requires a combination of tests, including the ACTH stimulation test, low-dose dexamethasone suppression test, and urine cortisol-to-creatinine ratio. The Peculiarities of feline hyperadrenocorticism: Update on diagnosis and treatment article provides a detailed review (Peculiarities of feline hyperadrenocorticism: Update on diagnosis and treatment, Journal of Feline Medicine and Surgery, 2017, https://pubmed.ncbi.nlm.nih.gov/28838299). The Feline adrenal disorders article also covers this topic (Feline adrenal disorders, Clinical Techniques in Small Animal Practice, 2007, https://pubmed.ncbi.nlm.nih.gov/17542194).

Primary Hyperaldosteronism (Conn's Syndrome)

Primary hyperaldosteronism is an underdiagnosed disorder in cats. It is caused by an aldosterone-secreting adrenal tumor or bilateral adrenal hyperplasia. Clinical signs include hypertension, hypokalemia, and associated signs such as weakness, lethargy, and cervical ventroflexion. Diagnosis is based on the demonstration of hypertension, hypokalemia, and elevated plasma aldosterone concentration with suppressed renin activity. The Primary Hyperaldosteronism in Cats: An Underdiagnosed Disorder article provides a comprehensive review (Primary Hyperaldosteronism in Cats: An Underdiagnosed Disorder, The Veterinary Clinics of North America. Small Animal Practice, 2020, https://pubmed.ncbi.nlm.nih.gov/32653266).

Hypoadrenocorticism (Addison's Disease)

Hypoadrenocorticism is rare in cats. It results from deficient production of glucocorticoids, mineralocorticoids, or both. Clinical signs are nonspecific and include lethargy, weakness, anorexia, vomiting, diarrhea, and weight loss. Diagnosis is based on the ACTH stimulation test. The Hypoadrenocorticism in cats: a 40-year update article provides a recent review (Hypoadrenocorticism in cats: a 40-year update, Journal of Feline Medicine and Surgery, 2024, https://pubmed.ncbi.nlm.nih.gov/39325772).

Diagnostic Differentiation

Differentiating between the common feline endocrinopathies requires careful integration of history, physical examination, and laboratory findings. The table below provides a guide for differentiation based on key diagnostic tests.

Practical Implementation Steps

Step 1: Obtain a Detailed History

A thorough history is the foundation of the diagnostic approach. Key questions include:

• What are the specific clinical signs and their duration?
• Has there been any change in appetite, water intake, or urination?
• Has there been any change in body weight?
• Has there been any change in behavior or activity level?
• Is the cat on any medications or supplements?
• Is there any history of previous illnesses or surgeries?

Step 2: Perform a Complete Physical Examination

A complete physical examination should include:

• Assessment of body condition and muscle mass
• Palpation of the ventral neck for thyroid nodules
• Cardiac auscultation for murmurs, arrhythmias, and tachycardia
• Abdominal palpation for organomegaly
• Neurologic examination, including assessment of gait and posture
• Fundic examination for hypertensive retinopathy

Step 3: Select Initial Diagnostic Tests

Based on the history and physical examination, select initial diagnostic tests. For most cats with suspected endocrine disease, a minimum database includes a complete blood count, serum biochemistry profile, and urinalysis. Specific endocrine tests are then added as indicated.

Step 4: Interpret Results and Formulate a Differential Diagnosis

Interpret the results of the initial tests and formulate a differential diagnosis. Consider the possibility of multiple concurrent endocrine disorders, such as diabetes mellitus and acromegaly, or hyperthyroidism and diabetes mellitus.

Step 5: Perform Confirmatory Testing

Perform confirmatory testing as needed. This may include additional endocrine tests, advanced imaging, or other specialized procedures.

Step 6: Develop a Management Plan

Develop a management plan based on the confirmed diagnosis. Consider the individual cat's needs, the presence of comorbidities, and owner preferences. The plan should include specific treatment recommendations, monitoring protocols, and follow-up schedules.

Observations and Measurements

Monitoring Glycemic Control in Diabetic Cats

Monitoring glycemic control is essential for managing diabetic cats. Methods include:

• Serial blood glucose curves: Measure blood glucose at regular intervals (e.g., every 2 hours) over a 12- to 24-hour period.
• Fructosamine: Measure every 4 to 6 weeks to assess average glycemic control.
• Owner observation: Monitor for clinical signs such as polyuria, polydipsia, and changes in appetite or body weight.
• Urine glucose and ketones: Monitor at home using urine test strips.

Monitoring Thyroid Hormone Levels in Hyperthyroid Cats

Monitoring thyroid hormone levels is essential for managing hyperthyroid cats. Methods include:

• Total T4: Measure every 2 to 4 weeks during the initial adjustment of methimazole therapy, then every 3 to 6 months once stable.
• Free T4 by equilibrium dialysis: Measure if total T4 is within the reference range but clinical signs persist.
• Clinical signs: Monitor for resolution of clinical signs such as weight loss, tachycardia, and hyperactivity.

Monitoring for Comorbidities

Cats with endocrine disorders are at increased risk for comorbidities. Regular monitoring for these conditions is important.

• Hypertension: Measure blood pressure at each visit.
• Chronic kidney disease: Monitor serum creatinine, blood urea nitrogen, and urine protein-to-creatinine ratio.
• Cardiac disease: Perform echocardiography as indicated.
• Pancreatitis: Monitor for clinical signs and consider measuring feline pancreatic lipase immunoreactivity.

Records and Documentation

Maintaining accurate records is essential for managing feline endocrine disorders. Key records include:

• Patient history: Include signalment, presenting complaints, and duration of signs.
• Physical examination findings: Document all findings, including body weight, body condition score, and any abnormalities.
• Diagnostic test results: Record all laboratory results, imaging findings, and other test results.
• Treatment plan: Document the specific treatment recommendations, including drug doses, administration instructions, and monitoring protocols.
• Follow-up schedule: Document the recommended follow-up schedule and any changes to the treatment plan.

Common Failure Patterns

Failure to Diagnose Concurrent Disorders

A common failure pattern is the failure to diagnose concurrent endocrine disorders. For example, a cat with diabetes mellitus may also have acromegaly or hyperthyroidism. A thorough diagnostic approach is essential to identify all concurrent disorders.

Inadequate Monitoring

Inadequate monitoring is another common failure pattern. For example, a diabetic cat may not have regular blood glucose curves or fructosamine measurements. This can lead to poor glycemic control and an increased risk of complications.

Poor Owner Compliance

Poor owner compliance can also lead to treatment failure. This may include failure to administer medications as prescribed, failure to follow dietary recommendations, or failure to attend follow-up appointments. Clear communication and owner education are essential to improve compliance.

Failure to Recognize and Manage Comorbidities

Failure to recognize and manage comorbidities is another common failure pattern. For example, a hyperthyroid cat with undiagnosed hypertension may be at increased risk for complications. Regular monitoring for comorbidities is essential.

Welfare and Safety Context

Welfare Considerations

Endocrine disorders can have a significant impact on the welfare of affected cats. Clinical signs such as polyuria, polydipsia, weight loss, and lethargy can cause discomfort and distress. Effective management of these disorders is essential to improve welfare. The World Organisation for Animal Health provides guidelines for animal health and welfare (World Organisation for Animal Health, https://www.woah.org/en/what-we-do/animal-health-and-welfare). The Assessing Cat Welfare: A Literature Review on Behavioural, Physiological and Health Parameters with a Focus on Animal-Assisted Services (AAS) article provides a framework for assessing cat welfare (Assessing Cat Welfare: A Literature Review on Behavioural, Physiological and Health Parameters with a Focus on Animal-Assisted Services (AAS), Veterinary Sciences, 2026, https://doi.org/10.3390/vetsci13060581).

Safety Considerations

Safety considerations include the risk of hypoglycemia in diabetic cats, the risk of thyroid storm in hyperthyroid cats, and the risk of hypertensive crisis in cats with hyperaldosteronism. Owners should be educated about the signs of these complications and when to seek veterinary care.

Professional Escalation Criteria

Veterinary clinicians should escalate care to a specialist (e.g., a veterinary internal medicine specialist) in the following situations:

• Difficulty achieving glycemic control in a diabetic cat
• Suspected acromegaly or other pituitary disorder
• Suspected hyperadrenocorticism or other adrenal disorder
• Presence of severe comorbidities
• Need for advanced imaging or specialized procedures

Limitations

Diagnostic Limitations

Diagnostic tests for feline endocrine disorders have limitations. For example, a single total T4 measurement may be within the reference range in a cat with mild hyperthyroidism. Stress hyperglycemia can complicate the diagnosis of diabetes mellitus. The ACTH stimulation test may not reliably diagnose hyperadrenocorticism in all cats.

Treatment Limitations

Treatment options for feline endocrine disorders have limitations. For example, medical therapy for hyperthyroidism requires lifelong administration and monitoring. Radioactive iodine therapy is not available in all areas. Insulin therapy for diabetes mellitus requires careful monitoring and dose adjustments. Radiation therapy for acromegaly may not be curative.

Owner Limitations

Owner limitations can also affect the management of feline endocrine disorders. These may include financial constraints, time constraints, and the ability to administer medications or monitor blood glucose at home.

Practical Decision Framework for Differentiating Feline Insulin-Resistant Diabetes

Insulin resistance in diabetic cats presents a common diagnostic challenge. When a diabetic cat requires more than 1.5 units per kilogram per dose of insulin or fails to achieve glycemic control despite appropriate insulin dosing, the clinician must systematically evaluate for underlying causes. This section provides a structured decision framework for differentiating the major causes of insulin resistance in cats, with emphasis on acromegaly, hyperadrenocorticism, and concurrent hyperthyroidism.

At a Glance: Causes of Insulin Resistance in Diabetic Cats

Step-by-Step Diagnostic Decision Framework

Step 1: Confirm Insulin Resistance

Before pursuing an extensive diagnostic workup, confirm that true insulin resistance exists. Measure blood glucose at the time of peak insulin effect, typically 4 to 6 hours after insulin administration. If blood glucose remains above 200 mg/dL at the expected peak effect, insulin resistance is likely. Document the current insulin dose in units per kilogram per dose. The 2023 AAHA Selected Endocrinopathies of Dogs and Cats Guidelines provide a framework for assessing glycemic control (2023 AAHA Selected Endocrinopathies of Dogs and Cats Guidelines, Journal of the American Animal Hospital Association, 2023, https://pubmed.ncbi.nlm.nih.gov/37167252).

Step 2: Review the History and Physical Examination

Obtain a detailed history focusing on:

• Insulin type, dose, and administration technique
• Diet type and feeding schedule
• Any recent medications, including topical or otic glucocorticoids
• Changes in body weight, appetite, water intake, and urination
• Any signs of concurrent illness

Perform a complete physical examination with attention to:

• Body condition score and muscle mass
• Palpation of the ventral neck for thyroid nodules
• Abdominal palpation for organomegaly
• Skin assessment for thin, fragile skin or poor wound healing
• Facial features for broad head or prognathia inferior
• Fundic examination for hypertensive retinopathy

Step 3: Perform Initial Laboratory Testing

The minimum database for a cat with suspected insulin resistance includes:

• Complete blood count
• Serum biochemistry profile with electrolytes
• Total T4
• Urinalysis with culture and sensitivity

The complete blood count may reveal evidence of infection or inflammation. The biochemistry profile may show elevated liver enzymes, azotemia, or electrolyte abnormalities. The total T4 screens for concurrent hyperthyroidism, which can cause insulin resistance. Urinalysis and culture identify urinary tract infections, which are common in diabetic cats and can contribute to insulin resistance.

Step 4: Evaluate for Acromegaly

If the history and physical examination suggest acromegaly, measure serum insulin-like growth factor-1 (IGF-1). An elevated IGF-1 concentration supports the diagnosis. However, IGF-1 can be falsely elevated in cats with poor glycemic control, so results must be interpreted in context. Confirmation requires demonstration of a pituitary mass on advanced imaging, such as CT or MRI. The Peculiarities of feline hyperadrenocorticism: Update on diagnosis and treatment article provides context on pituitary disorders in cats (Peculiarities of feline hyperadrenocorticism: Update on diagnosis and treatment, Journal of Feline Medicine and Surgery, 2017, https://pubmed.ncbi.nlm.nih.gov/28838299).

Step 5: Evaluate for Hyperadrenocorticism

If the history and physical examination suggest hyperadrenocorticism, begin with a urine cortisol-to-creatinine ratio. A normal result makes hyperadrenocorticism unlikely. An elevated result requires further testing with an ACTH stimulation test or low-dose dexamethasone suppression test. The Feline adrenal disorders article provides a detailed review of diagnostic testing (Feline adrenal disorders, Clinical Techniques in Small Animal Practice, 2007, https://pubmed.ncbi.nlm.nih.gov/17542194).

Step 6: Evaluate for Concurrent Hyperthyroidism

If the total T4 is elevated, hyperthyroidism is confirmed. If the total T4 is within the reference range but clinical suspicion remains high, measure free T4 by equilibrium dialysis. The 2016 AAFP Guidelines for the Management of Feline Hyperthyroidism provide detailed recommendations for diagnosis (2016 AAFP Guidelines for the Management of Feline Hyperthyroidism, Journal of Feline Medicine and Surgery, 2016, https://pubmed.ncbi.nlm.nih.gov/27143042).

Step 7: Consider Less Common Causes

If the above evaluations are negative, consider less common causes of insulin resistance, including:

• Primary hyperaldosteronism: Measure blood pressure and serum potassium. If hypertension and hypokalemia are present, measure plasma aldosterone concentration and renin activity. The Primary Hyperaldosteronism in Cats: An Underdiagnosed Disorder article provides a comprehensive review (Primary Hyperaldosteronism in Cats: An Underdiagnosed Disorder, The Veterinary Clinics of North America. Small Animal Practice, 2020, https://pubmed.ncbi.nlm.nih.gov/32653266).
• Hypoadrenocorticism: Although rare, hypoadrenocorticism can cause insulin resistance. Perform an ACTH stimulation test if clinical signs suggest this disorder. The Hypoadrenocorticism in cats: a 40-year update article provides a recent review (Hypoadrenocorticism in cats: a 40-year update, Journal of Feline Medicine and Surgery, 2024, https://pubmed.ncbi.nlm.nih.gov/39325772).
• Pancreatitis: Measure feline pancreatic lipase immunoreactivity if clinical signs suggest pancreatitis.

Record System for Tracking Insulin Resistance Cases

Maintaining a structured record system is essential for tracking cases of insulin resistance and monitoring response to treatment. The following template provides a framework for documentation.

Patient Information

• Patient name and identification number
• Signalment (age, breed, sex)
• Date of diabetes diagnosis
• Current insulin type and dose

Initial Assessment

• Date of initial assessment
• Presenting complaint
• Body weight and body condition score
• Physical examination findings
• Current blood glucose curve results
• Current fructosamine concentration

Diagnostic Workup

• Date of each diagnostic test
• Test results
• Interpretation
• Diagnosis

Treatment Plan

• Date of treatment initiation
• Treatment recommendations
• Insulin dose adjustments
• Monitoring schedule

Follow-up

• Date of each follow-up visit
• Body weight and body condition score
• Blood glucose curve results
• Fructosamine concentration
• Clinical response
• Any adverse events

Troubleshooting Method for Persistent Insulin Resistance

When a cat with insulin resistance does not respond to initial diagnostic and therapeutic interventions, use the following troubleshooting method.

Step 1: Re-evaluate the Diagnosis

Confirm that the initial diagnosis is correct. Review all diagnostic test results and consider repeating tests if results were equivocal. For example, a single normal urine cortisol-to-creatinine ratio does not completely rule out hyperadrenocorticism. Repeat the test if clinical suspicion remains high.

Step 2: Re-evaluate Insulin Therapy

Review the insulin type, dose, and administration technique. Ensure that the owner is administering the insulin correctly. Consider switching to a different insulin type. For example, some cats respond better to glargine than to detemir, or vice versa.

Step 3: Re-evaluate Diet and Feeding Schedule

Review the diet and feeding schedule. A high-protein, low-carbohydrate diet is recommended for diabetic cats. Ensure that the cat is eating consistently and that the feeding schedule is appropriate for the insulin type.

Step 4: Re-evaluate for Concurrent Disorders

Re-evaluate for concurrent disorders that may have been missed. Consider additional diagnostic tests, such as abdominal ultrasound, thoracic radiographs, or advanced imaging.

Step 5: Consider Referral to a Specialist

If insulin resistance persists despite a thorough diagnostic workup and appropriate treatment, refer the cat to a veterinary internal medicine specialist. The ACVIM provides a directory of board-certified specialists (ACVIM, https://www.acvim.org/).

Common Failure Patterns in Managing Insulin Resistance

Failure to Identify Concurrent Hyperthyroidism

Hyperthyroidism is a common cause of insulin resistance in older cats. Failure to measure total T4 in all diabetic cats with poor glycemic control is a common oversight. The Merck Veterinary Manual provides a general overview of cat health and common conditions (Merck Veterinary Manual, https://www.merckvetmanual.com/).

Failure to Consider Acromegaly

Acromegaly is often overlooked as a cause of insulin resistance. Clinicians may attribute poor glycemic control to owner noncompliance or inadequate insulin dosing without considering acromegaly. The hallmark of acromegaly is insulin resistance despite high insulin doses, often exceeding 1.5 units per kilogram per dose.

Failure to Perform Urinalysis with Culture

Urinary tract infections are common in diabetic cats and can cause insulin resistance. A routine urinalysis may not detect all infections. Urine culture and sensitivity should be performed in all diabetic cats with poor glycemic control.

Failure to Re-evaluate the Insulin Type

Some cats develop resistance to a particular insulin type over time. Switching to a different insulin type may improve glycemic control. For example, a cat that was well-controlled on glargine may develop resistance and respond better to detemir.

Welfare and Safety Context for Insulin Resistance Management

Welfare Considerations

Persistent hyperglycemia causes polyuria, polydipsia, weight loss, and lethargy, all of which negatively affect cat welfare. Diabetic ketoacidosis is a life-threatening complication of poorly controlled diabetes. Effective management of insulin resistance is essential to improve welfare and prevent complications. The World Organisation for Animal Health provides guidelines for animal health and welfare (World Organisation for Animal Health, https://www.woah.org/en/what-we-do/animal-health-and-welfare). The Assessing Cat Welfare: A Literature Review on Behavioural, Physiological and Health Parameters with a Focus on Animal-Assisted Services (AAS) article provides a framework for assessing cat welfare (Assessing Cat Welfare: A Literature Review on Behavioural, Physiological and Health Parameters with a Focus on Animal-Assisted Services (AAS), Veterinary Sciences, 2026, https://doi.org/10.3390/vetsci13060581).

Safety Considerations

Hypoglycemia is the most common adverse effect of insulin therapy. Owners should be educated about the signs of hypoglycemia, including weakness, lethargy, ataxia, seizures, and coma. They should have a plan for managing hypoglycemia, including administering glucose or honey and seeking veterinary care if necessary.

Professional Escalation Criteria

Veterinary clinicians should escalate care to a specialist in the following situations:

• Insulin dose exceeds 1.5 units per kilogram per dose without achieving glycemic control
• Suspected acromegaly or other pituitary disorder
• Suspected hyperadrenocorticism or other adrenal disorder
• Presence of severe comorbidities, such as diabetic ketoacidosis or pancreatitis
• Need for advanced imaging or specialized procedures

Observations and Measurements for Monitoring Response

Blood Glucose Curves

Serial blood glucose curves are the gold standard for assessing glycemic control. Measure blood glucose every 2 hours over a 12- to 24-hour period. The goal is to maintain blood glucose between 100 and 250 mg/dL for most of the day. Adjust insulin dose based on the nadir and duration of effect.

Fructosamine

Fructosamine reflects average blood glucose over the preceding 1 to 2 weeks. Measure fructosamine every 4 to 6 weeks to assess long-term glycemic control. A decreasing fructosamine concentration indicates improving glycemic control.

Clinical Signs

Monitor for resolution of clinical signs, including polyuria, polydipsia, polyphagia, and weight loss. Owners should keep a daily log of water intake, urination frequency, and appetite.

Body Weight

Monitor body weight at each visit. Weight gain indicates improving glycemic control. Weight loss may indicate poor glycemic control or concurrent disease.

Records and Documentation for Insulin Resistance Cases

Maintaining accurate records is essential for managing insulin resistance. Key records include:

• Patient history: Include signalment, presenting complaints, and duration of signs.
• Physical examination findings: Document all findings, including body weight, body condition score, and any abnormalities.
• Diagnostic test results: Record all laboratory results, imaging findings, and other test results.
• Treatment plan: Document the specific treatment recommendations, including insulin type, dose, administration instructions, and monitoring protocols.
• Follow-up schedule: Document the recommended follow-up schedule and any changes to the treatment plan.

Limitations of the Decision Framework

Diagnostic Limitations

Diagnostic tests for the causes of insulin resistance have limitations. For example, IGF-1 can be falsely elevated in cats with poor glycemic control. The ACTH stimulation test may not reliably diagnose hyperadrenocorticism in all cats. A single normal urine cortisol-to-creatinine ratio does not completely rule out hyperadrenocorticism.

Treatment Limitations

Treatment options for the underlying causes of insulin resistance have limitations. For example, radiation therapy for acromegaly may not be curative. Medical therapy for hyperadrenocorticism is not always effective. Surgical options are not widely available.

Owner Limitations

Owner limitations can affect the management of insulin resistance. These may include financial constraints, time constraints, and the ability to administer medications or monitor blood glucose at home. Clear communication and owner education are essential to improve compliance.

Frequently Asked Questions

What are the most common clinical signs of feline hyperthyroidism?

The most common clinical signs of feline hyperthyroidism include weight loss despite a good or increased appetite, hyperactivity, restlessness, vomiting, diarrhea, polyuria, and polydipsia. On physical examination, a palpable thyroid nodule, tachycardia, and a heart murmur are often present.

How is feline diabetes mellitus diagnosed?

Feline diabetes mellitus is diagnosed based on the presence of clinical signs (polyuria, polydipsia, polyphagia, weight loss), persistent hyperglycemia, and glucosuria. A single elevated blood glucose measurement must be interpreted with caution due to stress hyperglycemia. Fructosamine measurement can help confirm persistent hyperglycemia.

What is the relationship between acromegaly and diabetes mellitus in cats?

Acromegaly is caused by a growth hormone-secreting pituitary adenoma. Excess growth hormone leads to insulin resistance, which often results in diabetes mellitus. Acromegaly should be suspected in any diabetic cat with poor glycemic control despite high insulin doses.

What are the treatment options for feline hyperthyroidism?

Treatment options for feline hyperthyroidism include medical therapy with methimazole, dietary iodine restriction using a prescription diet, radioactive iodine therapy, and surgical thyroidectomy. The choice depends on the individual cat, the presence of comorbidities, and owner preferences.

How is glycemic control monitored in diabetic cats?

Glycemic control in diabetic cats is monitored using serial blood glucose curves, fructosamine measurements, and owner observation of clinical signs. Urine glucose and ketones can also be monitored at home.

What is the role of advanced imaging in the diagnosis of feline endocrine disorders?

Advanced imaging, such as CT and MRI, is used to identify pituitary masses in cats with acromegaly. Thyroid scintigraphy can be used to confirm the diagnosis of hyperthyroidism and identify the location of functional thyroid tissue.

What are the common comorbidities associated with feline endocrine disorders?

Common comorbidities associated with feline endocrine disorders include hypertension, chronic kidney disease, cardiac disease (hypertrophic cardiomyopathy), pancreatitis, and urinary tract infections. Regular monitoring for these conditions is important.

When should a cat with a suspected endocrine disorder be referred to a specialist?

A cat with a suspected endocrine disorder should be referred to a specialist (e.g., a veterinary internal medicine specialist) in cases of difficulty achieving glycemic control, suspected acromegaly or other pituitary disorder, suspected hyperadrenocorticism or other adrenal disorder, presence of severe comorbidities, or need for advanced imaging or specialized procedures.

Related Veterinary Guides

• Cat
• Clinical Biochemistry Urinalysis
• Hypertrophic Cardiomyopathy In Cats
• Prescription Medicine For Cats
• Sneezing Cat Remedy

References and Further Reading

• www.merckvetmanual.com
• catvets.com
• www.acvim.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• 2023 AAHA Selected Endocrinopathies of Dogs and Cats Guidelines.. Journal of the American Animal Hospital Association, 2023.
• Hypoadrenocorticism in cats: a 40-year update.. Journal of feline medicine and surgery, 2024.
• Primary Hyperaldosteronism in Cats: An Underdiagnosed Disorder.. The Veterinary clinics of North America. Small animal practice, 2020.
• Peculiarities of feline hyperadrenocorticism: Update on diagnosis and treatment.. Journal of feline medicine and surgery, 2017.
• Feline adrenal disorders.. Clinical techniques in small animal practice, 2007.
• 2016 AAFP Guidelines for the Management of Feline Hyperthyroidism.. Journal of feline medicine and surgery, 2016.
• Assessing Cat Welfare: A Literature Review on Behavioural, Physiological and Health Parameters with a Focus on Animal-Assisted Services (AAS). Veterinary Sciences, 2026.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.